News

INTERNATIONAL RESEARCHERS DISCUSS THE MICROBIOLOGICAL SAFETY OF WATER IN VIENNA

Novel Catalase for complete neutralization of H2O2 in agar plates

From years to days: Artificial Intelligence speeds up photodynamics simulations

Investment Plan for Europe – Successful launch of Tech Transfer Fund “KHAN-I”

An ERC Proof of Concept Grant has been awarded to IMP Group Leader Johannes Zuber. The funds will be used towards the development of a diagnostic platform for probing drug responses in cancer cells.

Fokus Krebstherapie: Aktuelle Forschungsergebnisse und Rolle der Kommunikation

Nabriva Therapeutics Earns $5 Million Milestone Payment under its License Agreement with Sinovant Sciences

Multidrug-resistant bacteria: urban brown rats as possible source

18 Teams wurden für den Gründerpreis PHÖNIX nominiert

SANOCHEMIA Pharmazeutika AG: Umsatz steigt konstant

Marsmission: Astronauten und Mikroben – (k)eine riskante Kombination?

The first Austrian Medtech company to be invited by the European Medicines Agency at its new location in Amsterdam.

ERC Starting Grant for CeMM PI Georg Winter

Renommierter ERC Starting Grant geht an IMBA Forscher Alejandro Burga

Start des aws Creat(iv)e Solutions Call: Bis zu 200.000 Euro für innovative Lösungen

T-cell prolymphocytic leukaemia: Scientific birth due to international consensus criteria from Vienna

Hämophilie: Bayer unterstützt Forschung und die Arbeit der Österreichischen Hämophiliegesellschaft

Marinomed: Investments in strong technology portfolio in first half-year 2019

Gemeinsam schneller forschen und entwickeln

A molecular "Trojan Horse"